The next board meeting for Amicus Therapeutics Inc is on 01 May 2025 for the purpose of Amicus Therapeutics Inc First Quarter Earnings Conference Call for 2025See details
Amicus Therapeutics Inc has a share price target of US$ 17, revenue growth forecast of 19.5%, and profit growth estimate of 113.4% for FY25, based on top 12 analyst calls.